DASATINIB
- Product NDC
- 62332-689
- 11-digit product format
- 623320689
- Labeler code
- 62332
- Product ID
- 62332-689_e31caab8-d233-412a-abc7-5416958c0264
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DASATINIB
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Alembic Pharmaceuticals Inc.
- Application
- ANDA216261
- Marketing category
- ANDA
- Marketing start
- 2025-11-11
- Substance
- DASATINIB
- Active strength
- 140 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| RBZ1571X5H | DASATINIB | 863127-77-9 | DASATINIB |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 62332-689-30 | 62332068930 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-689-30) | 2025-11-11 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| DASATINIB | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 2025-11-11 | Human Prescription Drug Label | 7 |